Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

36.04
Delayed Data
As of 4:02pm ET
 -0.07 / -0.19%
Today’s Change
25.98
Today|||52-Week Range
36.95
+11.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues219.7M233.4M243.2M210.0M
 
 
 
 
 
Cost of Goods Sold91.7M101.8M131.8M95.3M
 
 
 
 
 
Depreciation And Amortization22.7M22.7M22.2M22.5M
 
 
 
 
 
 
Operating ExpensesGross Income105.3M108.9M89.2M92.2M
 
 
 
 
 
General Expenses79.5M86.2M82.3M82.6M
 
 
 
 
 
Research And Development11.6M10.9M11.7M11.4M
 
 
 
 
 
Total Operating Expenses193.9M210.8M236.3M200.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income25.8M22.6M6.8M9.6M
 
 
 
 
 
Extraordinary Credit160.0K5.1M0.00--
 
 
 
Extraordinary Charge-6.7M-88.7M-12.4M-17.7M
 
 
 
 
 
Interest Expense On Debt2.8M2.4M2.7M1.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income16.6M-63.3M-8.3M-10.1M
 
 
 
 
 
Income Taxes-3.7M-3.9M-467.0K-288.0K
 
 
 
 
 
Net Income12.9M-59.4M-8.8M-10.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.7M50.7M50.9M51.0M
 
 
 
 
 
Shares To Calculate EPS Diluted51.2M50.7M50.9M51.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.25-$1.17-$0.17-$0.20
 
 
 
 
 
EPS Diluted$0.25-$1.17-$0.17-$0.20